Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-11-09
2010-06-08
Nguyen, Bao-Thuy L (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007200, C435S007910, C435S007940, C435S344100, C435S325000, C436S514000, C436S518000, C436S547000, C436S548000
Reexamination Certificate
active
07732156
ABSTRACT:
The present invention provides a new sensitive direct sandwich assay for determining the presence of COMP in a clinical sample. Two monoclonal antibodies directed against separate antigenic determinants of the COMP molecules are used in the assay. The invention also relates to three particularly advantageous monoclonal antibodies per se that are directed against human COMP. Cell cultures manufacturing these antibodies have been deposited according to the Budapest Treaty at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, and have been assigned accession numbers DSM ACC2406, DSM ACC2408 and DSM ACC2418, respectively. A diagnostic kit comprising at least two of these monoclonal antibodies also constitute a part of the present invention.
REFERENCES:
patent: 4778768 (1988-10-01), Heinegard et al.
patent: 6849594 (2005-02-01), Chen et al.
patent: 2788603 (2000-07-01), None
patent: WO96/01847 (1996-01-01), None
patent: WO98/07035 (1998-02-01), None
patent: WO98/46253 (1998-10-01), None
V. Vilim et al., “Characterization of Monoclonal Antibodies Recognizing Different Fragments of Cartilage Oligomeric Matrix Protein in Human Body Fluids”, Archives of Biochemistry and Biophysics, vol. 341, No. 1, pp. 8-16, (May 1997).
C. Marti et al., “Cartilage Oligomeric Matrix Protein (COMP): The Role of a Non-Collagen Cartilage Matrix Protein As a Marker of Disease Activity and Joint Destruction in Patients With Rheumatoid Arthritis and Osteoarthritis”, Abstract of Z. Rheumatol, vol. 58 (2), pp. 79-87, (1999).
M. Neidhart et al., “Small Fragments of Cartilage Oligomeric Matrix Protein in Synovial Fluid and Serum As Markers for Cartilage Degradation”, Abstract of Br. J. Rheumatol, vol. 36, pp. 1151-1160, (1997).
Sa Kuhne et al., “Persistent High Serum Levels of Cartilage Oligomeric Matrix Protein in a Subgroup of Patients With Traumatic Knee Injury”, Abstract of Rheumatol Int., vol. 18(1), pp. 21-25, (1998).
T. Saxne et al., “Cartilage Oligomeric Matrix Protein: A Novel Marker of Cartilage Turnover Detectable in Synovial Fluid and Blood”, British Journal of Rheumatology, vol. 31, pp. 583-591, (1992).
B. Mansson et al., “Cartilage and Bone Metabolism in Rheumatoid Arthritis Differences Between Rapid and Slow Progression of Disease Identified by Serum Markers of Cartilage Metabolism”, J. Clin. Invest., vol. 95, pp. 1071-1077, (Mar. 1995).
F.A. Wollheim et al., “HLA DRBI Typing and Cartilage Oligomeric Matrix Protein (COMP) As Predictors of Joint Destruction in Recent-Onset Rheumatoid Arthritis”, British Journal of Rheumatology, vol. 36, pp. 847-849, (1997).
I.F. Petersson et al., “Changes in Cartilage and Bone Metabolism Identified by Serum Markers in Early Osteoarthritis of the Knee Joint”, British Journal of Rheumatology, vol. 37, pp. 46-50, (1998).
E. Hedbom et al., “Cartilage Matrix Proteins. An Acidic Oligomeric Protein (COMP) Detected Only in Cartilage”, J. Biol. Chem., vol. 267, pp. 6132-6136, (Mar. 1992).
Hummel, et al.; Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids, Br. J. Rheumatol. vol. 37(7) pp. 721-728 (1998).
Communication Pursuant to Article 115(2) EPC and enclosed Third Party Observations from Rott, Ruzicka & Guttmann, dated Jul. 4, 2005 (EP 00979120.3).
Application for Grant No. NK 4887, Printed 2005.
Internet printout entitled “CEP—detail projektu”, containing data and footnotes of project No. NK4887 and English translation, Jan. 1998-Dec. 2000.
Declaration of the Research and Development Council of the Government of the Czech Republic of Jul. 23, 2004 and English translation.
Anamar Medical AB
Finnegan Henderson Farabow Garrett & Dunner LLP
Nguyen Bao-Thuy L
LandOfFree
Sandwich immunoassay and monoclonal antibodies for COMP,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sandwich immunoassay and monoclonal antibodies for COMP,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sandwich immunoassay and monoclonal antibodies for COMP,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4163845